Barclays says Apple’s (AAPL) 2024 saw another year with most of the stock performance driven by multiple expansion despite a weaker than ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

Investment firm Barclays laid out its thoughts for the technology space in 2025 in a research note on Thursday. Read for more ...

Fintel reports that on January 9, 2025, Barclays downgraded their outlook for Harmonic (NasdaqGS:HLIT) from Overweight to ...

Fintel reports that on January 8, 2025, Barclays upgraded their outlook for Tapestry (NYSE:TPR) from Equal-Weight to ...

Astera Labs excels in AI networking with innovative products but its high valuation warrants a Neutral rating.

Real household spending in Japan fell 0.4% year on year in November, a softer fall compared to the 0.6% decline expected by a ...

"Shawbrook’s PE owners eye £2bn IPO" was originally created and published by Leasing Life, a GlobalData owned brand.

Real household spending in Japan fell 0.4% year on year in November, a softer fall compared to the 0.6% decline expected by a ...

There was plenty of evidence to support such optimism. Stenn Assets UK Ltd., the firm’s main London-based subsidiary, reported $108 million of pretax profits for 2022 and 2023 combined and paid $56 ...

Barclays PLC BARC shares inched up 0.32% to £2.66 Thursday, on what proved to be an all-around positive trading session for ...

Millennium Management spinoff Modular Asset Management plans to expand to Hong Kong, the latest hedge fund arrival as the ...